New drug trial offers hope for painful skin condition
Disease control
Recruiting now
This study is testing whether an investigational drug called BFB759 can reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS). About 210 adults whose HS isn't well controlled by antibiotics will receive either BFB…
Phase: PHASE2, PHASE3 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC